CIK 0001746473 · Non-accelerated filer<br>Smaller reporting company
PLIANT THERAPEUTICS, INC.
Sign in to watch- Ticker
- PLRX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 474272481
- Phone
- 650-481-6770
- Business address
- 331 OYSTER POINT BOULEVARD, SOUTH SAN FRANCISCO, CA, 94080
- 4 Planned sale President and CEO sold 52,419 shares at $11.20 ($587,150)
- 4 Planned sale Chief Financial Officer sold 20,148 shares at $11.20 ($225,680)
- 4 Planned sale Chief Business Officer sold 15,936 shares at $11.20 ($178,501)
- 4 Planned sale Chief Medical Officer sold 18,478 shares at $11.20 ($206,974)
- 4 Planned sale Chief Human Resource Officer sold 3,740 shares at $11.20 ($41,892)
- 4 Planned sale General Counsel & Corp. Sec'y sold 23,500 shares at an average $11.11 ($261,101)
- 4 Planned sale Chief Medical Officer sold 12,319 shares at $11.56 ($142,408)
- 4 Planned sale Chief Business Officer sold 9,900 shares at $11.56 ($114,444)
- 4 Planned sale Chief Financial Officer sold 10,911 shares at $11.56 ($126,131)
- 4 Planned sale President and CEO sold 38,710 shares at $11.56 ($447,488)
- 4 Planned sale General Counsel & Corp. Sec'y sold 7,656 shares at $11.56 ($88,503)
- 4 Grant or award Chief Medical Officer acquired 24,063 shares (grant or award)
- 4 Grant or award Chief Business Officer acquired 19,337 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 21,313 shares (grant or award)
- 4 Grant or award President and CEO acquired 75,625 shares (grant or award)
- 4 Grant or award General Counsel & Corp. Sec'y acquired 14,954 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 3 of 11 · 215 filings